BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan FH, Bhat BA, Sheikh BA, Tariq L, Padmanabhan R, Verma JP, Shukla AC, Dowlati A, Abbas A. Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy. Semin Cancer Biol 2022;86:732-42. [PMID: 34273520 DOI: 10.1016/j.semcancer.2021.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Kalia VC, Lee JK, Rangappa KS, Gupta VK. Special issue Microbes in Cancer Research in 'Seminar in Cancer Biology' 2021. Semin Cancer Biol 2022;86:1102-4. [PMID: 34979275 DOI: 10.1016/j.semcancer.2021.12.014] [Reference Citation Analysis]
2 Zhang C, Xu S, Jiang Y, Jiang C, Li S, Wang Z, Dong Y, Jin F, Zhao D, Zhao Y, Li T. Construction and Evaluation of a Preoperative Prediction Model for Lymph Node Metastasis of cIA Lung Adenocarcinoma Using Random Forest. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/4008113] [Reference Citation Analysis]
3 Ma R, Cheng L, Song Y, Sun Y, Gui W, Deng Y, Xie C, Liu M. Altered Lung Microbiome and Metabolome Profile in Children With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease. Front Med 2022;9. [DOI: 10.3389/fmed.2022.940784] [Reference Citation Analysis]
4 Bao G, Li T, Guan X, Yao Y, Liang J, Xiang Y, Zhong X. Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma. Front Oncol 2022;12:880478. [DOI: 10.3389/fonc.2022.880478] [Reference Citation Analysis]
5 Stella GM, Scialò F, Bortolotto C, Agustoni F, Sanci V, Saddi J, Casali L, Corsico AG, Bianco A. Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review. Cancers 2022;14:3131. [DOI: 10.3390/cancers14133131] [Reference Citation Analysis]
6 Xi Y, Liu F, Qiu B, Li Y, Xie X, Guo J, Wu L, Liang T, Wang D, Wang J, Chen M, Xue L, Ding Y, Zhang J, Wu Q, Liu H. Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy. Front Cell Infect Microbiol 2022;12:892401. [DOI: 10.3389/fcimb.2022.892401] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu B, Yu Y, Zhao M, Xiao K, Yan P, Duan Z, Wang K, Zhao N, Cao J, Wang J, Xie L. Correlation Analysis of the Microbiome and Immune Function in the Lung-Gut Axis of Critically Ill Patients in the ICU. Front Med 2022;9:808302. [DOI: 10.3389/fmed.2022.808302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhou H, Yuan Y, Wang H, Xiang W, Li S, Zheng H, Wen Y, Ming Y, Chen L, Zhou J. Gut Microbiota: A Potential Target for Cancer Interventions. Cancer Manag Res 2021;13:8281-96. [PMID: 34764691 DOI: 10.2147/CMAR.S328249] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]